You will receive alerts when there are new announcements on Imugene Ltd
Only registered members can use this feature.
Imugene Ltd (ASX:IMU) is a clinical stage immuno-oncology company developing a range of new and novel immunotherapies that seek to activate the immune system of cancer patients to treat and eradicate tumors.
The company is well-funded to deliver on commercial and clinical milestones including the development of CF33, PD1-Vaxx and HER-Vaxx treatments.
Copyright © Proactive Investors 2021.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.